首页   >  
Ion Channel/Membrane Transporter
  • Neuro Signaling Pathway
  >  
P glycoprotein

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

P glycoprotein

结构式 货号 产品名称 CAS号
Encequidar 结构式
BCP25240 Encequidar 849675-66-7
Encequidar (HM30181) is a potent and selective inhibitor of P-glycoprotein.
Encequidar mesylate 结构式
BCP33772 Encequidar mesylate 849675-87-2
Encequidar mesylate (HM30181 mesylate) is a competitive and potent P-glycoprotein inhibitor.
Talinolol 结构式
BCP30483 内消旋-他林洛尔 57460-41-0
Talinolol is a beta(1)-adrenergic receptor antagonist and a probe drug for P-glycoprotein (P-gp) activity in humans.
Genz-123346 结构式
BCP11811 Genz-123346 491833-30-8
Genz-123346 is a potent and selective glucosylceramide synthase inhibitor with potential anticancer activity.
Cabazitaxel 结构式
BCP27641 卡巴他赛 183133-96-2
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
BAL27862 结构式
BCP16476 BAL27862 798577-91-0
BAL27862 is a a novel synthetic potent inhibitor of tubulin polymerization that induces cancer cell death. BAL27862 is a novel microtubule-destabilizing drug that is currently undergoing phase I clinical evaluation as the prodrug BAL101553. BAL27862 elicits a unique microtubule (MT) phenotype, distinct from paclitaxel, vinblastine and colchicine, has broad in vitro anti-proliferative activity against a diverse range of human tumor lines (low nM IC50s) and induces significant antitumor responses in a range
Piperine 结构式
BCP18901 胡椒碱 94-62-2
Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell.
Tariquidar methanesulfonate, hydrate 结构式
BCP18814 Tariquidar methanesulfonate, hydrate 625375-83-9
Tariquidar methanesulfonate, hydrate is a potent and specific inhibitor of P-glycoprotein (P-gp) with the high affinity (Kd=5.1±0.9 nM).
LY335979 结构式
BCP27664 唑喹达 167354-41-8
Zosuquidar (LY335979) is a potent negative modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM.
Elacridar 结构式
BCP05709 依克立达 143664-11-3
Elacridar is a P-glycoprotein and breast cancer resistance protein inhibitor that has been used to improve the brain distribution of drugs that are substrates of P-gp and BCRP.
12下一页共 15 条记录 1 / 2 页 
2853530911